A series of 2-arylamino-5-(indolyl)-1,3,4-thiadiazoles as potent cytotoxic agents. 2012

Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
Department of Chemistry, Birla Institute of Technology and Science, Pilani, Rajasthan 333 031, India. dalipk@bits-pilani.ac.in

A series of 2-arylamino-5-(indolyl)-1,3,4-thiadiazoles 6a-v were prepared and studied for their anticancer activity against selected human cancer cell lines. The reaction of indolylhydrazides 3a-h with a variety of aryl isothiocyanates 4 afforded the key intermediate thiosemicarbazides 5a-v, which upon treatment with acetyl chloride produced the 2-arylamino-5-(indolyl)-1,3,4-thiadiazoles 6a-v in good yields. Most of the synthesized compounds showed selective cytotoxicity towards human breast cancer cell line (MDA-MB-231). Of the synthesized 2-arylamino-5-(indolyl)-1,3,4-thiadiazoles, compound 6f is the most potent towards tested cancer cell lines (IC(50) = 0.15-1.18 μM).

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
July 1979, Bollettino chimico farmaceutico,
Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
February 1970, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft,
Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
September 2008, Acta pharmaceutica (Zagreb, Croatia),
Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
August 2001, Bioorganic & medicinal chemistry,
Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
May 1988, Journal of medicinal chemistry,
Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
June 2014, Bioorganic & medicinal chemistry letters,
Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
January 2003, Polish journal of pharmacology,
Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
September 2020, Acta pharmaceutica (Zagreb, Croatia),
Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
March 2015, European journal of medicinal chemistry,
Dalip Kumar, and N Maruthi Kumar, and Brett Noel, and Kavita Shah
March 2011, Archiv der Pharmazie,
Copied contents to your clipboard!